Cargando…

Surgical Outcomes of Glaucoma Drainage Device Implantation in Refractory Glaucoma Patients in Thailand

PURPOSE: To study the surgical outcomes of glaucoma drainage device (GDD) implantation in refractory glaucoma patients. PATIENTS AND METHODS: Retrospective chart review of glaucoma patients undergoing GDD implantation, Ahmed glaucoma valve (AGV), Baerveldt glaucoma implants (BGI), and Aurolab aqueou...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojananuangnit, Kulawan, Jiaranaisilawong, Prangkhwan, Rattanaphaithun, Onvipa, Sathim, Wanwisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760067/
https://www.ncbi.nlm.nih.gov/pubmed/36540897
http://dx.doi.org/10.2147/OPTH.S393730
_version_ 1784852376563220480
author Rojananuangnit, Kulawan
Jiaranaisilawong, Prangkhwan
Rattanaphaithun, Onvipa
Sathim, Wanwisa
author_facet Rojananuangnit, Kulawan
Jiaranaisilawong, Prangkhwan
Rattanaphaithun, Onvipa
Sathim, Wanwisa
author_sort Rojananuangnit, Kulawan
collection PubMed
description PURPOSE: To study the surgical outcomes of glaucoma drainage device (GDD) implantation in refractory glaucoma patients. PATIENTS AND METHODS: Retrospective chart review of glaucoma patients undergoing GDD implantation, Ahmed glaucoma valve (AGV), Baerveldt glaucoma implants (BGI), and Aurolab aqueous drainage implantation (AADI) from January 2012 to June 2021. Glaucoma patients were classified into two groups: primary glaucoma including: primary open angle glaucoma (POAG), primary angle closure glaucoma (PACG) and juvenile open angle glaucoma (JOAG) and secondary glaucoma including: neovascular glaucoma (NVG), ocular surgery (vitreoretinal surgery, scleral buckling procedure, postoperative extra capsular cataract extraction, scleral fixation intraocular lens, penetrating keratoplasty), intraocular trauma, uveitis glaucoma, lens-induced glaucoma, pseudoexfoliation glaucoma (PXG), iridocorneal endothelial (ICE) syndromes and Axenfeld Rieger Syndrome. Surgical outcomes were studied. RESULTS: Primary glaucoma included 57 eyes from 49 patients. Secondary glaucoma included 87 eyes from 85 patients. The cumulative probability of complete or qualified success of refractory glaucoma patients at five years were 53.4% (95%CI: 38.4%, 66.3%). Higher success rate was discovered in primary glaucoma at 65.8% (95%CI: 38.4%, 83.3%) than 45.2% (95%CI: 26.9%, 61.9%) in secondary glaucoma group significantly with p=0.003. While the results among success rate, adverse events and complications was not different between types of GDD. Predictors for failure were neovascular glaucoma with unadjusted hazard ratio (HR) 3.62 (95%CI: 1.45, 9.04) with p=0.006, and lens-induced glaucoma with adjusted HR 4.19 (95%CI: 1.10, 15.86) with p=0.035 in multivariable analysis. Tube malposition and occlusion were the most frequent adverse events at 11.11%, corneal decompensation at 5.5%, hypotony at 2% in the nonvalved group, and endophthalmitis at 0.69%. CONCLUSION: Surgical success in refractory primary glaucoma was superior to secondary glaucoma with no difference between nonvalved and valved GDD implantation. Lens-induced glaucoma was a strong predictor for failure in GDD implantation.
format Online
Article
Text
id pubmed-9760067
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-97600672022-12-19 Surgical Outcomes of Glaucoma Drainage Device Implantation in Refractory Glaucoma Patients in Thailand Rojananuangnit, Kulawan Jiaranaisilawong, Prangkhwan Rattanaphaithun, Onvipa Sathim, Wanwisa Clin Ophthalmol Original Research PURPOSE: To study the surgical outcomes of glaucoma drainage device (GDD) implantation in refractory glaucoma patients. PATIENTS AND METHODS: Retrospective chart review of glaucoma patients undergoing GDD implantation, Ahmed glaucoma valve (AGV), Baerveldt glaucoma implants (BGI), and Aurolab aqueous drainage implantation (AADI) from January 2012 to June 2021. Glaucoma patients were classified into two groups: primary glaucoma including: primary open angle glaucoma (POAG), primary angle closure glaucoma (PACG) and juvenile open angle glaucoma (JOAG) and secondary glaucoma including: neovascular glaucoma (NVG), ocular surgery (vitreoretinal surgery, scleral buckling procedure, postoperative extra capsular cataract extraction, scleral fixation intraocular lens, penetrating keratoplasty), intraocular trauma, uveitis glaucoma, lens-induced glaucoma, pseudoexfoliation glaucoma (PXG), iridocorneal endothelial (ICE) syndromes and Axenfeld Rieger Syndrome. Surgical outcomes were studied. RESULTS: Primary glaucoma included 57 eyes from 49 patients. Secondary glaucoma included 87 eyes from 85 patients. The cumulative probability of complete or qualified success of refractory glaucoma patients at five years were 53.4% (95%CI: 38.4%, 66.3%). Higher success rate was discovered in primary glaucoma at 65.8% (95%CI: 38.4%, 83.3%) than 45.2% (95%CI: 26.9%, 61.9%) in secondary glaucoma group significantly with p=0.003. While the results among success rate, adverse events and complications was not different between types of GDD. Predictors for failure were neovascular glaucoma with unadjusted hazard ratio (HR) 3.62 (95%CI: 1.45, 9.04) with p=0.006, and lens-induced glaucoma with adjusted HR 4.19 (95%CI: 1.10, 15.86) with p=0.035 in multivariable analysis. Tube malposition and occlusion were the most frequent adverse events at 11.11%, corneal decompensation at 5.5%, hypotony at 2% in the nonvalved group, and endophthalmitis at 0.69%. CONCLUSION: Surgical success in refractory primary glaucoma was superior to secondary glaucoma with no difference between nonvalved and valved GDD implantation. Lens-induced glaucoma was a strong predictor for failure in GDD implantation. Dove 2022-12-14 /pmc/articles/PMC9760067/ /pubmed/36540897 http://dx.doi.org/10.2147/OPTH.S393730 Text en © 2022 Rojananuangnit et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Rojananuangnit, Kulawan
Jiaranaisilawong, Prangkhwan
Rattanaphaithun, Onvipa
Sathim, Wanwisa
Surgical Outcomes of Glaucoma Drainage Device Implantation in Refractory Glaucoma Patients in Thailand
title Surgical Outcomes of Glaucoma Drainage Device Implantation in Refractory Glaucoma Patients in Thailand
title_full Surgical Outcomes of Glaucoma Drainage Device Implantation in Refractory Glaucoma Patients in Thailand
title_fullStr Surgical Outcomes of Glaucoma Drainage Device Implantation in Refractory Glaucoma Patients in Thailand
title_full_unstemmed Surgical Outcomes of Glaucoma Drainage Device Implantation in Refractory Glaucoma Patients in Thailand
title_short Surgical Outcomes of Glaucoma Drainage Device Implantation in Refractory Glaucoma Patients in Thailand
title_sort surgical outcomes of glaucoma drainage device implantation in refractory glaucoma patients in thailand
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760067/
https://www.ncbi.nlm.nih.gov/pubmed/36540897
http://dx.doi.org/10.2147/OPTH.S393730
work_keys_str_mv AT rojananuangnitkulawan surgicaloutcomesofglaucomadrainagedeviceimplantationinrefractoryglaucomapatientsinthailand
AT jiaranaisilawongprangkhwan surgicaloutcomesofglaucomadrainagedeviceimplantationinrefractoryglaucomapatientsinthailand
AT rattanaphaithunonvipa surgicaloutcomesofglaucomadrainagedeviceimplantationinrefractoryglaucomapatientsinthailand
AT sathimwanwisa surgicaloutcomesofglaucomadrainagedeviceimplantationinrefractoryglaucomapatientsinthailand